UNSPSC 51281668: Spectinomycin hydrochloride

This classification denotes an aminoglycoside antibiotic with the molecular formula C14H24N2O7.2ClH.5H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HWT06H303Z, chemically known as 4h-pyrano(2,3-b)(1,4)benzodioxin-4-one, decahydro-4a,7,9-trihydroxy-2-methyl-6,8-bis(methylamino)-, dihydrochloride, pentahydrate but more generally known as spectinomycin dihydrochloride pentahydrate, which bears US NIH Compound Identifier 30971.

UNSPSC 51281668 Spectinomycin hydrochloride is a Commodity code that covers pharmaceutical active pharmaceutical ingredients and finished-form antibiotic products, though recent state and local procurement activity under this code shows minimal alignment with the nominal scope. The two most recent state and local contract opportunities posted under or near this taxonomy do not actually involve spectinomycin hydrochloride. Instead, the Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through the MMCAP Infuse consortium to Chartwell Rx LLC for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets — different antibiotics with different therapeutic applications — while Seminole County, Florida solicited Naloxone and Safe Drug Deactivation Systems, which are not antibiotics at all. The mismatch suggests either inconsistent code assignment in state procurement databases or that the code itself captures a broader pharmaceutical-supply category than the product name implies. State and local health departments and counties appear to be the primary issuing bodies, but the recent opportunities do not support characterization of an active, dedicated market for spectinomycin hydrochloride specifically.

The Illinois opportunity (Solicitation Number 26482DPHPREPDB53392, posted August 28, 2026, with a response deadline of September 11, 2026) was an IFB through cooperative purchasing that awarded $2,999,999.11 over a 12-month initial term plus two renewal options to Chartwell Rx LLC. The Seminole County opportunity (Solicitation Number IFB60459723LAS, posted June 30, 2026, with a response deadline of July 26, 2023) was an IFB seeking 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries. The geographic spread evident in recent activity includes Illinois and Florida. No active, open solicitations specifically for spectinomycin hydrochloride are present in the available state and local contract opportunity records.